Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings outcomes as we speak.
Reported gross sales elevated 5.2% year-over-year to $22.5 billion.
GAAP earnings decreased 37.5% to $2.7 billion whereas EPS fell 34% to $1.11 in comparison with final 12 months. Adjusted EPS was down 9% to $2.42.
For full-year 2024, JNJ expects reported gross sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.
(This story can be up to date shortly with an infographic)
Investors are grappling with elevated oil prices and persistent geopolitical tensions, but those who can ignore short-term noise may be...
US Federal Reserve Chair Jerome Powell arrives for a press conference following the Federal Open Market Committee meeting at the...
Long before NVIDIA $NVDA became the most valuable company in the world we theorized that’s what would happen. No crystal...
Life takes us all on a journey. One that ultimately defines us as individuals. For some of you, that path...
JetBlue Airways Corporation surged 9.3% Friday to close at $6.02 as the airline announced new summer seasonal service between Boston...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
